An article written by Daniel Fisher at Forbes.com quotes Larry Ebner about the significance of Food and Drug Administration approval of label warnings that are alleged to be inadequate in failure-to-warn suits.
“The Supreme Court seems to make it more confusing every time it issues one of these decisions,” Ebner said.